Intoxicación con sulfato de magnesio en preeclampsia y eclampsia

Abstract

Introduction: for decades, magnesium sulfate in the obstetric field has been widely used to prevent and/or treat seizures during the gestation period, since in essence it acts by preventing seizures by blocking neuromuscular transmission as well as reducing released acetylcholine. by the neuronal plate at the end of the motor impulse. General objective: Describe magnesium sulfate poisoning in preeclampsia and eclampsia through a bibliographic review. Methodology: narrative bibliographic review in studies, meta-analysis, systematic reviews, controlled clinical trials, cohort studies, bibliographic reviews that report magnesium sulfate poisoning in patients with preeclampsia and eclampsia from 2018 to 2023, in English languages. Results: 32 articles were chosen, where we found that the maternal symptoms of magnesium sulfate poisoning are redness, muscle weakness, nausea, respiratory and cardiac arrest. Maternal complications of poisoning are hyporeflexia, tremors, bradycardia, and muscle weakness. Neonatal symptoms of poisoning are bradycardia, hypotonia, hypoglycemia, and the use of non-invasive mechanical ventilation. Conclusions: Magnesium poisoning is associated with an increased risk of maternal and perinatal mortality and morbidity.